Related Experiment Video
Updated: Jun 3, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Beyond "Advanced": proposing Fluctuation-Dominant Parkinson's disease as a functional alternative to enable timely
Shivam Om Mittal1, Wolfgang H Jost2,3
1Parkinsons Disease and Movement Disorders Center, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE. neurology.mittal@gmail.com.
The term "advanced Parkinson's disease" deters eligible patients from crucial device-aided therapy (DAT). Replacing it with "fluctuation-dominant Parkinson's disease" (FD-PD) better reflects patient experience and therapeutic needs.
Area of Science:
- Neurology
- Movement Disorders
- Patient-Reported Outcomes
Background:
- The label "advanced Parkinson's disease" (PD) negatively impacts patient perception and therapy referral.
- Current "early" vs. "advanced" PD terminology fails to capture the prolonged intermediate disease phase.
- This terminology creates a psychological barrier, leading eligible patients to reject beneficial device-aided therapy (DAT).
Purpose of the Study:
- To address the terminological barriers hindering DAT referral in Parkinson's disease.
- To propose a new descriptor that accurately reflects patient experience and therapeutic needs.
- To reframe the conversation from disease severity to therapeutic opportunity.
Main Methods:
- Analysis of current terminology in Parkinson's disease guidelines and patient materials.
- Conceptual proposal of a new descriptor: "fluctuation-dominant Parkinson's disease" (FD-PD).
- Discussion of the functional and psychological implications of proposed terminology shift.
Main Results:
- The term "advanced PD" is clinically imprecise, emotionally harmful, and counterproductive for therapy access.
- FD-PD accurately describes patients experiencing significant motor and non-motor fluctuations.
- FD-PD decouples therapy eligibility from overall disease burden and names the intermediate disease phase.
Conclusions:
- Replacing "advanced PD" with FD-PD can improve patient understanding and access to DAT.
- FD-PD offers a functional, mechanism-based descriptor that aligns with therapeutic goals.
- International evaluation is recommended to formally adopt FD-PD or a similar descriptor.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Alterations in Muscle Tone lll

